Mackay Shields LLC’s IQ U.S. Mid Cap R&D Leaders ETF MRND Stock Holding History

Mackay Shields LLC’s Portfolio MRND Stock Details MRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-190,000	Closed	-$4.81M	–	728
2022 Q1	$4.81M	Buy	+190,000	New	+$4.7M	0.04%	362

Other funds holding MRND

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Mackay Shields LLC's MRND Position: Q2 2022 in Review

Mackay Shields LLC sold out of IQ U.S. Mid Cap R&D Leaders ETF (MRND) in Q2 2022, closing a stake of 190,000 shares — an estimated $4.81M sold.

Mackay Shields LLC first reported a position in MRND in Q1 2022 and held it in 1 quarter. The position peaked at $4.81M in Q1 2022. 2 funds tracked by Wall St. Rank hold MRND as of Q2 2022.

Mackay Shields LLC reported no remaining IQ U.S. Mid Cap R&D Leaders ETF position as of Q2 2022 after selling out during the quarter.
Mackay Shields LLC sold 190,000 IQ U.S. Mid Cap R&D Leaders ETF shares in Q2 2022, an estimated $4.81M.
Mackay Shields LLC first reported a position in IQ U.S. Mid Cap R&D Leaders ETF in Q1 2022 and held it in 1 quarter.
Mackay Shields LLC's IQ U.S. Mid Cap R&D Leaders ETF position peaked at $4.81M in Q1 2022.
2 funds tracked by Wall St. Rank held IQ U.S. Mid Cap R&D Leaders ETF as of Q2 2022.

Based on Mackay Shields LLC's 13F filing for Q2 2022, filed 3 Aug 2022.